Docosahexaenoic Acid Supplementation of Women With Hypertension in Pregnancy to Improve Endothelial Health

Withdrawn before enrolling · Not applicable

Conditions studied: Hypertension in Pregnancy

In brief

The Investigator would like to see if taking a DHA supplement at a dose recommended for heart health will improve brachial artery dilation (relaxation) and help blood pressure. As a second goal the Investigator would like to see if this supplement can delay preterm delivery by improving heart health. In this research study, the Investigator is asking pregnant women with chronic high blood pressure to take Expecta (DHA - Martek Biosciences, now known as DSM Nutritional Lipil) during the last half of their pregnancy until six weeks after they deliver their baby.

Key facts

Study ID

NCT02137408

Run by

Children's Hospital Medical Center, Cincinnati

People needed

0

Starts

2014-12-01

Expected to finish

2016-04-01

Last updated by the study team

2014-09-18

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Pregnant women coming for their 19-20 week ultrasound for fetal anatomy and that have been diagnosed with hypertension by their Obstetrician will be eligible for inclusion.

You may not qualify if…

• Exclusions to enrollment will include: women < 18 years old
• Bleeding disorders
• Lupus
• Autoimmune diseases
• The presence of infant congenital (trisomy 13,18, 21, urethral, gastrointestinal and cardiac defects)

Where it is running

• Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.